Double stranded RNA-dependent protein kinase is involved in osteoclast differentiation of RAW264.7 cells in vitro

Experimental Cell Research

Volumn 316, Issue 19, 2010, Pages 3254-3262

  Teramachi, Junpei ^a   Morimoto, Hiroyuki ^b   Baba, Ryoko ^b   Doi, Yoshiaki ^b   Hirashima, Kanji ^a   Haneji, Tatsuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

DC STAMP; MFR; NF B; Osteoclast; PKR; RAW264.7

Indexed keywords

2 AMINOPURINE; ARGININE; CALCITONIN RECEPTOR; CATHEPSIN K; COMPLEMENTARY DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2; LYSINE; MEMBRANE PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN KINASE R; STAT1 PROTEIN;

ALPHA CHAIN; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELL; ENZYME PHOSPHORYLATION; GENE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; OSTEOCLAST; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; BONE DEVELOPMENT; CELL FUSION; CYTOLOGY; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION;

EUKARYOTA;

ANIMALS; CELL DIFFERENTIATION; CELL FUSION; CELL LINE; EIF-2 KINASE; EUKARYOTIC INITIATION FACTOR-2; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MICE; MUTATION; NF-KAPPA B; OSTEOCLASTS; OSTEOGENESIS; PHOSPHORYLATION;

EID: 77958087289     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2010.08.006     Document Type: Article

References (41)

1. Garcia M.A., Meurs E.F., Esteban M. The dsRNA protein kinase PKR: virus and cell control. Biochimie 2007, 89:799-811.
2. Sadler A.J., Williams B.R.G. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8:559-568.
3. Kumar A., Haque J., Lacoste J., Hiscott J., Williams B.R.G. Double-stranded RNA-dependent protein kinase activates transcription factor NF-κB by phosphorylating IκB. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:6288-6292.
4. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2001, 2:835-841.
5. Morimoto H., Ozaki A., Okamura H., Yoshida K., Kitamura S., Haneji T. Okadaic acid induces tyrosine phosphorylation of IκBα that mediated by PKR pathway in human osteoblastic MG63 cells. Mol. Cell. Biochem. 2005, 276:211-217.
6. de Haro C., Méndez R., Santoyo J. The eIF-2α kinases and the control of protein synthesis. FASEB J. 1996, 10:1378-1387.
7. Morimoto H., Okamura H., Yoshida K., Kitamura S., Haneji T. Okadaic acid induces apoptosis through double-stranded RNA-dependent protein kinase/eukaryotic initiation factor-2α pathway in human osteoblastic MG63 cells. J. Biochem. 2004, 136:433-438.
8. Roodman G.D. Regulation of osteoclast differentiation. Ann. NY Acad. Sci. 2006, 1068:100-109.
9. Teitelbaum S.L. Osteoclasts: what do they do and how do they do it?. Am. J. Pathol. 2007, 170:427-435.
10. Saginario C., Sterling H., Beckers S., Kobayashi R., Solimena M., Ullu E., Vignery A. MFR, a putative receptor mediating the fusion of macrophages. Mol. Cell. Biol. 1998, 18:6213-6223.
11. Hartgers F.C., Vissers J.L.M., Looman M.W.G., van Zoelen C., Huffine C., Figdor C.G., Adema G.J. DC-STAMP, a novel multimembrane-spanning molecule preferentially expressed by dendritic cells. Eur. J. Immunol. 2000, 30:3585-3590.
12. Tanaka S., Nakamura K., Takahasi N., Suda T. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system. Immunol. Rev. 2005, 208:30-49.
13. Wada T., Nakashima T., Nishina H., Penninger J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol. Med. 2006, 12:17-25.
14. Jimi E., Ghosh S. Role of nuclear factor-κB in the immune system and bone. Immunol. Rev. 2005, 208:80-87.
15. Soysa N.S., Alles N. NF-κB function in osteoclasts. Biochem. Biophys. Res. Commun. 2009, 378:1-5.
16. Ha H., Lee J.H., Kim H.N., Kwak H.B., Kim H.M., Lee S.E., Rhee J.H., Kim H.H., Lee Z.H. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-β. J. Immunol. 2008, 180:1382-1389.
17. Yoshida K., Okamura H., Amorim B.R., Ozaki A., Tanaka H., Morimoto H., Haneji T. Double-stranded RNA-dependent protein kinase is required for bone calcification in MC3T3-E1 cells in vitro. Exp. Cell Res. 2005, 311:117-125.
18. Yoshida K., Okamura H., Amorim B.R., Hinode D., Yoshida H., Haneji T. PKR-mediated degradation of STAT1 regulates osteoblast differentiation. Exp. Cell Res. 2009, 315:2105-2114.
19. Meurs E., Chong K., Galabru J., Thomas N.S.B., Kerr I.M., Williams B.R.G., Hovanessian A.G. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990, 62:379-390.
20. Takizawa T., Ohashi K., Nakanishi Y. Possible involvement of double-stranded RNA-activated protein kinase in cell death by influenza virus infection. J. Virol. 1996, 70:8128-8132.
21. Takeda Y., Tachibana I., Miyado K., Kobayashi M., Miyazaki T., Funakoshi T., Kimura H., Yamane H., Saito Y., Goto H. Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes. J. Cell Biol. 2003, 161:945-956.
22. de Vries T.J., Schoenmaker T., Beertsen W., van der Neut R., Evers V. Effects of CD44 deficiency on in vitro and in vivo osteoclast formation. J. Cell. Biochem. 2005, 94:954-966.
23. Jagus R., Joshi B., Barber G.N. PKR, apoptosis and cancer. Int. J. Biochem. Cell Biol. 1999, 31:123-138.
24. Shogren K.L., Turner R.T., Yaszemski M.J., Maran A. Double-stranded RNA-dependent protein kinase is involved in 2-methoxyestradiol-mediated cell death of osteosarcoma cells. J. Bone Miner. Res. 2007, 22:29-36.
25. Han X., Sterling H., Chen Y., Saginario C., Brown E.J., Frazier W.A., Lindberg F.P., Vignery A. CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J. Biol. Chem. 2000, 275:37984-37992.
26. Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J. Exp. Med. 2005, 202:337-340.
27. Kukita T., Wada N., Kukita A., Kakimoto T., Sandra F., Toh K., Nagata K., Iijima T., Horiuchi M., Matsusaki H., Hieshima K., Yoshie O., Nomiyama H. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J. Exp. Med. 2004, 200:941-946.
28. Yagi M., Miyamoto T., Sawatani Y., Iwamoto K., Hosogane N., Fujita N., Morita K., Ninomiya K., Suzuki T., Miyamoto K., Oike Y., Takeya M., Toyama Y., Suda T. DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 2005, 202:345-351.
29. Yang Y.L., Reis L.F., Pavlovic J., Aguzzi A., Schafer R., Kumar A., Williams B.R.G., Aguet M., Weissmann C. Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 1995, 14:6095-6106.
30. Elkins T., Zinn K., McAllister L., Hoffmann F.M., Goodman C.S. Genetic analysis of drosophila neural cell adhesion molecule: interaction of fasciclin I and abelson tyrosine kinase mutations. Cell 1990, 60:565-575.
31. Maggi L.B., Heitmeier M.R., Scheuner D., Kaufman R.J., Buller R.M.L., Corbett J.A. Potential role of PKR in double-stranded RNA-induced macrophage activation. EMBO J. 2000, 19:3630-3638.
32. Pereira R.M., Teixeira K.L.D., Barreto-de-Souza V., Calegari-Silva T.C., De-Melo L.D.B., Soares D.C., Bou-Habib D.C., Silva A.M., Saraiva E.M., Lopes U.G. Novel role for the double-stranded RNA-activated protein kinase PKR: modulation of macrophage infection by the protozoan parasite Leishmania. FASEB J. 2010, 24:617-626.
33. Tsuji-Naito K. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation. Bioorg. Med. Chem. 2008, 16:9176-9183.
34. Rahman M.M., Bhattacharya A., Fernandes G. Docosahexaenoic acid is more potent inhibitor of osteoclast differentiation in RAW 264.7 cells than eicosapentaenoic acid. J. Cell. Physiol. 2008, 214:201-209.
35. Ang E.S.M., Pavlos N.J., Chai L.Y., Qi M., Cheng T.S., Steer J.H., Joyce D.A., Zheng M.H., Xu J. Caffeic acid phenethyl ester, an active component of honeybee propolis attenuates osteoclastogenesis and bone resorption via the suppression of RANKL-induced NF-κB and NFAT activity. J. Cell. Physiol. 2009, 221:642-649.
36. Lin R.W., Chen C.H., Wang Y.H., Ho M.L., Hung S.H., Chen I.S., Wang G.J. (-)-Epigallocatechin gallate inhibition of osteoclastic differentiation via NF-κB. Biochem. Biophys. Res. Commun. 2009, 379:1033-1037.
37. Tam N.W.N., Ishii T., Li S., Wong A.H., Cuddihy A.R., Koromilas A.E. Upregulation of STAT1 protein in cells lacking or expressing mutants of the double-stranded RNA-dependent protein kinase PKR. Eur. J. Biochem. 1999, 262:149-154.
38. Takayanagi H., Kim S., Koga T., Taniguchi T. Stat1-mediated cytoplasmic attenuation in osteoimmunology. J. Cell. Biochem. 2005, 94:232-240.
39. Furukawa M., Takaishi H., Takito J., Yoda M., Sakai S., Hikata T., Hakozaki A., Uchikawa S., Matsumoto M., Chiba K., Kimura T., Okada Y., Matsuo K., Yoshida H., Toyama Y. IL-27 abrogates receptor activator of NF-κB ligand-mediated osteoclastogenesis of human granulocyte-macrophage colony-forming unit cells through STAT1-dependent inhibition of c-Fos. J. Immunol. 2009, 183:2397-2406.
40. Kim K., Lee J., Kim J.H., Jin H.M., Zhou B., Lee S.Y., Kim N. Protein inhibitor of activated STAT3 modulates osteoclastogenesis by down-regulation of NFATc1 and osteoclast-associated receptor. J. Immunol. 2007, 178:5588-5594.
41. Duplomb L., Baud'huin M., Charrier C., Berreur M., Trichet V., Blanchard F., Heyman D. Interleukin-6 inhibits receptor activator of nuclear factor κB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3. Endocrinology 2008, 149:3688-3697.